Viagra had no impact on saquinavir pharmacokinetics. A more robust CYP3A4 inhibitor like ketoconazole or itraconazole can be anticipated to have increased result than that seen with saquinavir. Population pharmacokinetic knowledge from sufferers in scientific trials also indicated a discount in sildenafil clearance when it had been co-administered